[go: up one dir, main page]

ES2102870T3 - Benzopiranos y composiciones farmaceuticas que los contienen. - Google Patents

Benzopiranos y composiciones farmaceuticas que los contienen.

Info

Publication number
ES2102870T3
ES2102870T3 ES94924788T ES94924788T ES2102870T3 ES 2102870 T3 ES2102870 T3 ES 2102870T3 ES 94924788 T ES94924788 T ES 94924788T ES 94924788 T ES94924788 T ES 94924788T ES 2102870 T3 ES2102870 T3 ES 2102870T3
Authority
ES
Spain
Prior art keywords
sub
compounds
group
ring
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94924788T
Other languages
English (en)
Inventor
Alexandra Roderick Mackenzie
Sandra Marina Monaghan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Research and Development Co NV SA
Original Assignee
Pfizer Research and Development Co NV SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Research and Development Co NV SA filed Critical Pfizer Research and Development Co NV SA
Application granted granted Critical
Publication of ES2102870T3 publication Critical patent/ES2102870T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA INVENCION SE REFIERE A COMPUESTOS DE LA FORMULA (I) Y A LAS SALES FARMACOLOGICAMENTE ACEPTABLES DE LOS MISMOS EN DONDE X ES O, S O NH; R Y R1 SE SELECCIONAN INDEPENDIENTEMENTE ENTRE H Y ALQUILO C{SUB,1-4} O TOMADAS JUNTAS REPRESENTAN ALQUILENO C{SUB,2-6}; R2 ES H O ALQUIL C{SUB,1-4}; R3 ES A) UN ANILLO HETEROCICLICO DE SEIS MIEMBROS QUE CONTIENEN 1 O 2 HETEROATOMOS N UNIDOS A X POR UN ATOMO DE CARBONO DEL ANILLO Y OPCIONALMENTE BENZOFUNDIDOS Y OPCIONALMENTE SUSTITUIDOS, B) CUANDO X ES NH, UN GRUPO DE LA FORMULA (I), O C) CUANDO X ES NH, UN GRUPO DE LA FORMULA (J); Y R4 ES FENILO SUSTITUIDO POR UN GRUPO DE HIDROXIDO Y OPCIONALMENTE SUSTITUIDO DE FORMA ADICIONAL POR UNO O DOS SUSTITUYENTES; TAMBIEN SE PRESENTAN LAS COMPOSICIONES QUE CONTIENEN LOS COMPUESTOS, EL USO DE LAS MISMAS, PROCESOS PARA LA PREPARACION Y PRODUCTOS INTERMEDIOS USADOS EN LA PREPARACION DE DICHOS COMPUESTOS.
ES94924788T 1993-08-04 1994-07-18 Benzopiranos y composiciones farmaceuticas que los contienen. Expired - Lifetime ES2102870T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939316111A GB9316111D0 (en) 1993-08-04 1993-08-04 Benzopyrans

Publications (1)

Publication Number Publication Date
ES2102870T3 true ES2102870T3 (es) 1997-08-01

Family

ID=10739921

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94924788T Expired - Lifetime ES2102870T3 (es) 1993-08-04 1994-07-18 Benzopiranos y composiciones farmaceuticas que los contienen.

Country Status (28)

Country Link
US (2) US5912244A (es)
EP (1) EP0712398B1 (es)
JP (1) JP2871098B2 (es)
KR (1) KR0175532B1 (es)
CN (1) CN1128536A (es)
AT (1) ATE152716T1 (es)
AU (1) AU684817B2 (es)
CA (1) CA2168563C (es)
CO (1) CO4230234A1 (es)
CZ (1) CZ281853B6 (es)
DE (1) DE69403084T2 (es)
DK (1) DK0712398T3 (es)
EC (1) ECSP941140A (es)
EG (1) EG20525A (es)
ES (1) ES2102870T3 (es)
FI (1) FI960487A0 (es)
GB (1) GB9316111D0 (es)
GR (1) GR3023521T3 (es)
HU (1) HUT75120A (es)
IL (1) IL110488A (es)
NO (1) NO960441L (es)
NZ (1) NZ271344A (es)
PE (1) PE56894A1 (es)
PL (1) PL312788A1 (es)
SG (1) SG42817A1 (es)
TW (1) TW333532B (es)
WO (1) WO1995004730A1 (es)
ZA (1) ZA945774B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5573758A (en) * 1995-04-28 1996-11-12 Allergan Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers
US5869478A (en) * 1995-06-07 1999-02-09 Bristol-Myers Squibb Company Sulfonamido substituted benzopyran derivatives
ES2199362T3 (es) * 1996-06-07 2004-02-16 Vanderbilt University Dihidrobenzopirano y compuestos relacionados utiles como agentes anti-inflamatorios.
US6333352B1 (en) * 2000-04-05 2001-12-25 Mimicking Man Manually, Inc. Method of treating benign positional vertigo
PT1818325E (pt) * 2001-04-16 2010-05-12 Schering Corp Ciclobuteno-1,2-dionas 3,4-di-substituídas como ligandos de receptor de quimoquina cxc
CA2461381A1 (en) * 2001-10-04 2003-04-10 Wyeth Chroman derivatives as 5-hydroxytryptamine-6 ligands
NZ539903A (en) * 2002-11-12 2008-02-29 Warner Lambert Co Method of stimulating hair growth using benzopyrans
CN1917878A (zh) * 2004-02-12 2007-02-21 沃尼尔·朗伯有限责任公司 刺激毛发生长的方法
US20090110892A1 (en) * 2004-06-30 2009-04-30 General Electric Company System and method for making a graded barrier coating
CN1984650A (zh) * 2004-07-16 2007-06-20 沃尼尔·朗伯有限责任公司 毛发生长促进剂
US20070225357A1 (en) * 2004-07-19 2007-09-27 Pfizer Inc. Formulation for Stimulating Hair Growth
CA2591810A1 (en) * 2004-12-21 2006-06-29 F.Hoffmann-La Roche Ag Chroman derivatives and uses thereof in the treatment of cns disorders

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3835011A1 (de) * 1988-10-14 1990-04-19 Merck Patent Gmbh Chromanderivate
ES2058148T3 (es) * 1987-02-04 1994-11-01 Hoechst Ag N-benzopiranil-lactamas sustituidas con alquilo, procedimiento para su preparacion, su empleo, asi como preparados farmaceuticos a base de estos compuestos.
DE3703227A1 (de) * 1987-02-04 1988-08-18 Hoechst Ag Substituierte 3,4-dihydro-2h-benzopyrane, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen
DE3811017A1 (de) * 1988-03-31 1989-10-19 Hoechst Ag Ungesaettigte n-benzopyranyllactame
AU628331B2 (en) * 1988-05-06 1992-09-17 Merck Patent Gesellschaft Mit Beschrankter Haftung Chroman derivatives
EP0346724A1 (de) * 1988-06-16 1989-12-20 MERCK PATENT GmbH Chromanderivate
DE3824446A1 (de) * 1988-07-19 1990-01-25 Hoechst Ag, 6230 Frankfurt Verwendung substituierter 3,4-dihydro-2h-benzopyrane als heilmittel gegen obstruktive funktionsstoerungen der lunge und/oder stoerungen der ableitenden harnwege
DE3827532A1 (de) * 1988-08-13 1990-03-01 Hoechst Ag 6-aroyl-substituierte 3,4-dihydro-2h-benzopyrane, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen
DE3918041A1 (de) * 1989-06-02 1990-12-06 Merck Patent Gmbh Chromanderivate
US5061813A (en) * 1990-04-02 1991-10-29 E. R. Squibb & Sons, Inc. Substituted cyanoimino benzopyranes
GB2242628A (en) * 1990-04-06 1991-10-09 Sandoz Ltd Asthma prophylactic use of K+ channel activators
TW244350B (es) * 1991-12-14 1995-04-01 Hoechst Ag
FI930148L (fi) * 1992-01-18 1993-07-19 Hoechst Ag Foerfarande foer enantioselektiv epoxidation av i 6-staellning substituerade kromener

Also Published As

Publication number Publication date
EG20525A (en) 1999-06-30
AU684817B2 (en) 1998-01-08
SG42817A1 (en) 1997-10-17
ATE152716T1 (de) 1997-05-15
US5912244A (en) 1999-06-15
NO960441D0 (no) 1996-02-02
FI960487A7 (fi) 1996-02-02
JPH08508042A (ja) 1996-08-27
IL110488A (en) 1999-08-17
CO4230234A1 (es) 1995-10-19
IL110488A0 (en) 1994-10-21
CZ33196A3 (en) 1996-05-15
HUT75120A (en) 1997-04-28
CA2168563C (en) 1999-09-07
DE69403084T2 (de) 1997-08-14
GB9316111D0 (en) 1993-09-22
DE69403084D1 (de) 1997-06-12
US6071938A (en) 2000-06-06
JP2871098B2 (ja) 1999-03-17
ECSP941140A (es) 1995-01-16
GR3023521T3 (en) 1997-08-29
PL312788A1 (en) 1996-05-13
CN1128536A (zh) 1996-08-07
FI960487L (fi) 1996-02-02
ZA945774B (en) 1996-02-05
DK0712398T3 (da) 1997-10-27
CZ281853B6 (cs) 1997-02-12
PE56894A1 (es) 1995-02-07
NZ271344A (en) 1997-10-24
WO1995004730A1 (en) 1995-02-16
EP0712398A1 (en) 1996-05-22
EP0712398B1 (en) 1997-05-07
CA2168563A1 (en) 1995-02-16
NO960441L (no) 1996-02-02
FI960487A0 (fi) 1996-02-02
KR0175532B1 (ko) 1999-02-18
TW333532B (en) 1998-06-11
AU7494894A (en) 1995-02-28

Similar Documents

Publication Publication Date Title
ES2053508T3 (es) Compuestos de acidos 3-pirrolidinil-tio-1-azabiciclo(3.2.0)hept-2-eno-2-carboxilicos.
ES2058527T3 (es) Derivados de pirimidina condensados procedimiento y compuestos intermedios para su preparacion y composiciones farmaceuticas que los contienen.
ES2011210T3 (es) Derivados de gem-difosfonato substituido, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ES2062395T3 (es) Nuevos compuestos de bencimidazol y su uso.
ES2083773T3 (es) Derivados de 1,3-dihidro-2h-imidazo(4,5-b)quinolin-2-ona como inhibidores de fosfodiesterasa.
ES2104946T3 (es) Ureas ciclicas y similares utiles como inhibidores de la proteasa retrovirica.
DK0457686T3 (da) Hidtil ukendte aminopiperidin-, aminopyrrolidin- og aminoperhydroazepinderivater, fremgangsmåder til fremstilling heraf og farmaceutiske midler, som indeholder dem
ES2062987T3 (es) Compuestos de actividad farmaceutica.
ES2081187T3 (es) Nuevas naftil-alquil-aminas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
AR248138A1 (es) Un procedimiento de preparacion de acilamino-2-tiazoles.
AR009413A1 (es) Un compuesto, el cual es un derivado de distamicina benzoheterociclico, su utilizacion, un procedimiento para producirlo y una composicionfarmaceutica que lo comprende
ES2045180T3 (es) Nuevo procedimiento para la obtencion de 4-aciloxi-3-hidroxietil-azetidinonas.
ES2102870T3 (es) Benzopiranos y composiciones farmaceuticas que los contienen.
ES2039242T3 (es) Un procedimiento para la preparacion de nuevos derivados de piperidina.
ES2118203T3 (es) Nuevos derivados benzopiranicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ES2123560T3 (es) Composiciones farmaceuticas que comprenden derivados de hidroxamato para la eliminacion del hierro.
ES2056073T3 (es) Aril-aralquil-eteres, procedimientos para su preparacion y composicion farmaceutica que los comprende.
FI803264L (fi) 2-hydroxialkyl-3,4,5-trihydroxipiperidiner foerfarande foer framstaellning av dem och anvaendning av dem som laekemedel
ES2043863T3 (es) Procedimiento para preparar derivados de la 1,2,5,6-tetrahidropiridina.
ES2090024T3 (es) Compuestos de cefemo y procedimientos para su preparacion.
ES2029879T3 (es) Procedimiento para producir derivados de aminas sustituidas.
ES2070002T3 (es) Composiciones terapeuticas a base de derivados de 1,2-ditiol-3-tiona.
ES2063117T3 (es) Derivados del tieno(2,3-d)acepina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ES2043834T3 (es) Un procedimiento para preparar nuevos derivados de androsta-1,4-dien-3-ona sustituida en la posicion 17.
ES2075976T3 (es) Derivados de aminoacido y su empleo como agentes antiviricos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 712398

Country of ref document: ES